1. Home
  2. AM vs BMRN Comparison

AM vs BMRN Comparison

Compare AM & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Antero Midstream Corporation

AM

Antero Midstream Corporation

HOLD

Current Price

$22.47

Market Cap

10.2B

Sector

Utilities

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$57.43

Market Cap

10.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AM
BMRN
Founded
2013
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2B
10.9B
IPO Year
2017
1999

Fundamental Metrics

Financial Performance
Metric
AM
BMRN
Price
$22.47
$57.43
Analyst Decision
Hold
Buy
Analyst Count
4
18
Target Price
$22.50
$88.22
AVG Volume (30 Days)
2.3M
1.8M
Earning Date
04-29-2026
04-30-2026
Dividend Yield
3.95%
N/A
EPS Growth
3.61
N/A
EPS
0.86
1.80
Revenue
$1,188,426,000.00
$1,313,646,000.00
Revenue This Year
$4.92
$14.30
Revenue Next Year
$6.74
$11.65
P/E Ratio
$26.49
$31.21
Revenue Growth
7.43
17.62
52 Week Low
$15.52
$50.76
52 Week High
$23.84
$66.28

Technical Indicators

Market Signals
Indicator
AM
BMRN
Relative Strength Index (RSI) 48.52 51.83
Support Level $22.45 $56.32
Resistance Level $23.84 $60.06
Average True Range (ATR) 0.55 1.31
MACD -0.18 0.27
Stochastic Oscillator 22.97 91.83

Price Performance

Historical Comparison
AM
BMRN

About AM Antero Midstream Corporation

Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin, located in West Virginia and Ohio. The company has two operating segments: the Gathering and Processing segment, which includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio, and the Water Handling segment, which includes two independent systems that deliver water from sources including the Ohio River, local reservoirs, and several regional waterways. The company derives a majority of its revenue from the Gathering and Processing segment.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: